Cubist Systematic Strategies’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Cubist Systematic Strategies’s Portfolio HARP Stock Details HARP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,476	Closed	-$119K	–	4452
2023 Q4	$119K	Buy	+10,476	New	+$82.3K	﹤0.01%	3145
2022 Q3	–	Sell	-321	Closed	-$6K	–	4904
2022 Q2	$6K	Sell	321 -1,534	-83%	-$39.7K	﹤0.01%	4294
2022 Q1	$92K	Buy	1,855 +1,775	+2,219%	+$92K	﹤0.01%	3268
2021 Q4	$6K	Sell	80 -4,432	-98%	-$302K	﹤0.01%	3408
2021 Q3	$356K	Buy	4,512 +3,524	+357%	+$354K	﹤0.01%	2247
2021 Q2	$137K	Sell	988 -34	-3%	-$6.49K	﹤0.01%	2666
2021 Q1	$214K	Buy	1,022 +1,016	+16,933%	+$204K	﹤0.01%	2427
2020 Q4	$1K	Sell	6 -201	-97%	-$31.1K	﹤0.01%	2535
2020 Q3	$35K	Buy	+207	New	+$29.9K	﹤0.01%	2388

Cubist Systematic Strategies's HARP Position: Q1 2024 in Review

Cubist Systematic Strategies sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2024, closing a stake of 10,476 shares — an estimated $119K sold.

Cubist Systematic Strategies first reported a position in HARP in Q3 2020 and held it in 9 quarters. The position peaked at $356K in Q3 2021. 0 funds tracked by Wall St. Rank hold HARP as of Q1 2024.

Cubist Systematic Strategies reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Cubist Systematic Strategies sold 10,476 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $119K.
Cubist Systematic Strategies first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q3 2020 and held it in 9 quarters.
Cubist Systematic Strategies's Harpoon Therapeutics, Inc. Common Stock position peaked at $356K in Q3 2021.
0 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Cubist Systematic Strategies's 13F filing for Q1 2024, filed 15 May 2024.